Stanford University
Stanford, California, 94305, United States
Location status: Recruiting
Location contact
Archana Verma
CONTACT
Jean Louis-Horn, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT03230565
The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 4
Stanford, California, 94305, United States
Location status: Recruiting
Archana Verma
CONTACT
Jean Louis-Horn, MD
PRINCIPAL_INVESTIGATOR
Regional anesthetic techniques are an integral part to many anesthetic approaches, providing both intraoperative and postoperative anesthesia and analgesia. Regional anesthesia peripheral nerve blocks have been shown to reduce postoperative pain and improve measures such as opioid requirements and readiness for discharge. By using a catheter technique for continuous peripheral nerve blocks, analgesia can be extended well into post-operative days 2 and 3, further extending these benefits. Historically these catheters have implemented a continuous dosing regimen of local anesthetic, but increasingly there is evidence of improved analgesic outcomes without adverse effects by using a scheduled bolus dosing regimen. Many institutions have implemented this new protocol for catheter dosing. The beneficial effect of scheduled bolus dosing has not been studied in all blocks and all surgical procedures.
The study will consist of three independent arms, each designed to evaluate a different nerve block site: interscalene, adductor canal, and infraclavicular. A total of 60 patients will be enrolled in each arm.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient will be given a continuous infusion of local anesthetic.
Other names: Continuous infusion
Time frame: Post-operative day 0, 1, and 2
Pain scores will be collected using a Numeric Rating Scale (NRS) from 0-10, where 0 is the lowest and 10 is the highest pain level.
Time frame: Post-operative day 0, 1, and 2
The amount of opioid analgesics (converted to total morphine milligram equivalents) taken by patients will be recorded.
Time frame: Post-operative day 1 and 2
The amount of supplemental local anesthetic boluses self-administered by patients will be recorded (in mL).
Time frame: Post-operative day 1 and 2
Quality of recovery will be assessed using a Quality of Recovery (QoR-15) questionnaire. The QoR15 scores range from 0 to 150, where 0 is poor recovery and 150 is excellent recovery.
Time frame: Post-operative day 1 and 2
Ability to breathe will be assessed as a part of QoR-15 questionnaire on 11-point scale, where 0 is never being able to breathe easily and 10 is always being able to breathe easily.
Time frame: Post-operative day 1 and 2
Patients will be asked to assess their satisfaction with pain management (Yes/No).
Contact information is provided by the study sponsor or research team.
Stanford University
Other
A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06844630
Arthralgia, Joint Diseases
Samsun, Turkey (Türkiye)
View Trial DetailsNCT05444517
Arthralgia, Diaphragmatic Paralysis
Santiago, Santiago Metropolitan, Chile
View Trial DetailsNCT02352922
Neurologic Manifestations, Pain
Orlando, Florida, United States
View Trial DetailsNCT03411343
Arthralgia, Diaphragmatic Paralysis
Santiago, Santiago Metropolitan, Chile
View Trial Details